This inventor holds 50 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Controlled Release Formulations (CPC class 4244). Top assignees: Edward Mendell Co., Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Company. Active years: 1991-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Poughkeepsie, NY (US) (1991 - 1992)
- Wappinger Falls, NY (US) (2000 - 2005)
- Wapppingers Falls, NY (US) (2016)
- Wappingers Falls, NY (US) (1992 - 2019)
Company Filing History:
28 out of 47 
11 out of 32 
10 out of 11 Years Active: 1991-2019
Areas of Expertise:
Title: Innovations of Anand R. Baichwal in Sustained Release Formulations
Introduction
Anand R. Baichwal, a prominent inventor based in Wappingers Falls, NY, has made significant strides in the pharmaceutical field. With a remarkable portfolio of 50 patents, he has focused on creating effective medicinal formulations that aim to enhance patient care.
Latest Patents
One of Baichwal's latest patents revolves around sustained release formulations of nalbuphine. This includes methods for making these formulations and ways to utilize them for treating patients suffering from pain. The development of these pharmaceutically acceptable salts represents a noteworthy advancement in pain management, highlighting Baichwal's commitment to innovation in healthcare.
Career Highlights
Throughout his career, Anand R. Baichwal has worked with several noteworthy companies, including Edward Mendell Company, Inc. and Endo Pharmaceuticals Inc. His contributions to these organizations have significantly influenced their product lines and research capabilities.
Collaborations
Baichwal has collaborated with skilled professionals like John N. Staniforth and Philip A. Goliber. These partnerships have fostered an environment of innovation and have collectively led to the development of effective pharmaceutical solutions.
Conclusion
Anand R. Baichwal's legacy in the realm of sustained release formulations exemplifies the impact of dedicated inventors in the pharmaceutical industry. His innovative approaches to pain management not only showcase his inventiveness but also contribute to improved patient outcomes. As he continues to advance his research, the potential for future inventions remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile